Scilex Holding (SCLX) Non-cash Items (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Non-cash Items of $953000.0 for Q1 2026, up 1366.15% on a QoQ basis from $65000.0 in Q3 2025.

Scilex Holding (SCLX) Non-cash Items (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Non-cash Items for 7 consecutive years, with $953000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-cash Items changed N/A year-over-year to $953000.0; the TTM figure through Mar 2026 stood at $953000.0 (changed N/A YoY), while the FY2023 annual figure was $25452.0, down 99.93% from the prior year.
  • Non-cash Items came in at $953000.0 for Q1 2026 at Scilex Holding, up from $65000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $112.0 million in Q1 2023, with the low at $1000.0 in Q2 2025.
  • Average Non-cash Items over 5 years is $17.9 million, with a median of $953000.0 recorded in 2026.
  • Across the five-year window, Non-cash Items soared 125877.42% in 2024 and sank 100.0% in 2025, its largest moves.
  • Year by year, Non-cash Items stood at $38.9 million in 2022, then slumped by 99.93% to $25452.0 in 2023, then jumped by 88898.9% to $22.7 million in 2024, then slumped by 99.71% to $65000.0 in 2025, then surged by 1366.15% to $953000.0 in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods registered $953000.0, $65000.0, and $1000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 953,000.00
Mar 31, 2026 953,000.00
Sep 30, 2025 812,000.00
Sep 30, 2025 812,000.00
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 756,000.00
Mar 31, 2025 756,000.00
Sep 30, 2024 224,000.00
Sep 30, 2024 224,000.00
Jun 30, 2024 21.38 Mn
Jun 30, 2024 21.38 Mn
Mar 31, 2024 20,174.00
Mar 31, 2024 20,174.00
Dec 31, 2023 25,452.00
Dec 31, 2023 25,452.00
Sep 30, 2023 17,981.00
Sep 30, 2023 17,981.00
Jun 30, 2023 17,099.00
Jun 30, 2023 17,099.00